GENOSPECTRA ANNOUNCES THE ACQUISITION OF PANOMICS, A LEADING REAGENTS PROVIDER
Genospectra, Inc., developer of innovative products and technologies for Parallel
Quantitative Biology TM, and the exclusive provider of QuantiGene and QuantiGene
Plex products for gene expression profiling, announced today that it is merging
with Panomics, Inc., a leading provider of life sciences research reagents for
transcription regulation, cell signaling and signal transduction.